Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 91 (3) , 438-442
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)Lung Cancer, 2008
- Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient SurvivalThe Annals of Thoracic Surgery, 2008
- A1-05: Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs)Journal of Thoracic Oncology, 2007
- A Pilot Study of [18F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- Optimization of megavoltage CT scan registration settings for thoracic cases on helical tomotherapyPhysics in Medicine & Biology, 2007
- Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patientsAnnals of Oncology, 2006
- Early Variations of Circulating Interleukin-6 and Interleukin-10 Levels During Thoracic Radiotherapy Are Predictive for Radiation PneumonitisJournal of Clinical Oncology, 2005
- Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureLung Cancer, 2005
- Concurrent chemoradiotherapy in non-small cell lung cancer2004
- Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyLung Cancer, 2004